
Diana B. Johannsen
Examiner (ID: 9339, Phone: (571)272-0744 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1682, 1655 |
| Total Applications | 1005 |
| Issued Applications | 399 |
| Pending Applications | 208 |
| Abandoned Applications | 415 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10208797
[patent_doc_number] => 20150093787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR USE IN RECOMBINATIONAL CLONING OF NUCLEIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 14/452517
[patent_app_country] => US
[patent_app_date] => 2014-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 253
[patent_figures_cnt] => 253
[patent_no_of_words] => 55759
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14452517
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/452517 | COMPOSITIONS AND METHODS FOR USE IN RECOMBINATIONAL CLONING OF NUCLEIC ACIDS | Aug 4, 2014 | Abandoned |
Array
(
[id] => 11004178
[patent_doc_number] => 20160201127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'METHODS AND PROBES FOR MONITORING MARINE WATER'
[patent_app_type] => utility
[patent_app_number] => 14/909075
[patent_app_country] => US
[patent_app_date] => 2014-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7959
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14909075
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/909075 | Methods and probes for monitoring marine water | Jul 27, 2014 | Issued |
Array
(
[id] => 10282084
[patent_doc_number] => 20150167081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'METHODS OF ASSESSING THE RISK OF REPRODUCTIVE FAILURE BY MEASURING TELOMERE LENGTH'
[patent_app_type] => utility
[patent_app_number] => 14/323638
[patent_app_country] => US
[patent_app_date] => 2014-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13094
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323638
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/323638 | METHODS OF ASSESSING THE RISK OF REPRODUCTIVE FAILURE BY MEASURING TELOMERE LENGTH | Jul 2, 2014 | Abandoned |
Array
(
[id] => 10247756
[patent_doc_number] => 20150132752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'METHOD FOR DETERMINING HLA-A*24 GROUP'
[patent_app_type] => utility
[patent_app_number] => 14/315806
[patent_app_country] => US
[patent_app_date] => 2014-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8011
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14315806
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/315806 | METHOD FOR DETERMINING HLA-A*24 GROUP | Jun 25, 2014 | Abandoned |
Array
(
[id] => 9806582
[patent_doc_number] => 20150018527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY'
[patent_app_type] => utility
[patent_app_number] => 14/307708
[patent_app_country] => US
[patent_app_date] => 2014-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 28027
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14307708
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/307708 | Methods and materials for assessing loss of heterozygosity | Jun 17, 2014 | Issued |
Array
(
[id] => 10961404
[patent_doc_number] => 20140364434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-11
[patent_title] => 'Biomarkers for Prediction of Response to PARP Inhibition in Breast Cancer'
[patent_app_type] => utility
[patent_app_number] => 14/298849
[patent_app_country] => US
[patent_app_date] => 2014-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 34443
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14298849
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/298849 | Biomarkers for Prediction of Response to PARP Inhibition in Breast Cancer | Jun 5, 2014 | Abandoned |
Array
(
[id] => 11507592
[patent_doc_number] => 09598739
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-03-21
[patent_title] => 'Human erythrovirus'
[patent_app_type] => utility
[patent_app_number] => 14/288691
[patent_app_country] => US
[patent_app_date] => 2014-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 18449
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14288691
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/288691 | Human erythrovirus | May 27, 2014 | Issued |
Array
(
[id] => 13805353
[patent_doc_number] => 10179938
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-15
[patent_title] => Artificial selection method and reagents
[patent_app_type] => utility
[patent_app_number] => 14/245334
[patent_app_country] => US
[patent_app_date] => 2014-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28114
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 430
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14245334
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/245334 | Artificial selection method and reagents | Apr 3, 2014 | Issued |
Array
(
[id] => 10686254
[patent_doc_number] => 20160032400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'METHOD FOR THE PROGNOSIS AND TREATMENT OF CANCER METASTASIS'
[patent_app_type] => utility
[patent_app_number] => 14/776412
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 32491
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776412
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776412 | METHOD FOR THE PROGNOSIS AND TREATMENT OF CANCER METASTASIS | Mar 13, 2014 | Abandoned |
Array
(
[id] => 9932047
[patent_doc_number] => 20150080239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'Classification and Actionability Indices for Cancer'
[patent_app_type] => utility
[patent_app_number] => 14/212717
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23561
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14212717
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/212717 | Classification and Actionability Indices for Cancer | Mar 13, 2014 | Abandoned |
Array
(
[id] => 10687364
[patent_doc_number] => 20160033509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'DIAGNOSTIC AND PROGNOSTIC MARKER FOR PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/775229
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6065
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775229
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/775229 | DIAGNOSTIC AND PROGNOSTIC MARKER FOR PROSTATE CANCER | Mar 13, 2014 | Abandoned |
Array
(
[id] => 9757418
[patent_doc_number] => 20140288116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'Classification and Actionability Indices for Lung Cancer'
[patent_app_type] => utility
[patent_app_number] => 14/212115
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45485
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14212115
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/212115 | Classification and Actionability Indices for Lung Cancer | Mar 13, 2014 | Abandoned |
Array
(
[id] => 10694101
[patent_doc_number] => 20160040247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'METHOD FOR THE DIAGNOSIS, PROGNOSIS, AND TRATMENT OF CANCER METASTASIS'
[patent_app_type] => utility
[patent_app_number] => 14/776453
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 27788
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776453
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776453 | METHOD FOR THE DIAGNOSIS, PROGNOSIS, AND TRATMENT OF CANCER METASTASIS | Mar 13, 2014 | Abandoned |
Array
(
[id] => 10912186
[patent_doc_number] => 20140315199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'GENE FUSIONS AND GENE VARIANTS ASSOCIATED WITH CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/214300
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 68000
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14214300
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/214300 | GENE FUSIONS AND GENE VARIANTS ASSOCIATED WITH CANCER | Mar 13, 2014 | Abandoned |
Array
(
[id] => 10911774
[patent_doc_number] => 20140314792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER METASTASIS'
[patent_app_type] => utility
[patent_app_number] => 14/213670
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 27687
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14213670
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/213670 | METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER METASTASIS | Mar 13, 2014 | Abandoned |
Array
(
[id] => 9793240
[patent_doc_number] => 20150005184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'DIAGNOSIS OF MELANOMA BY NUCLEIC ACID ANALYSIS'
[patent_app_type] => utility
[patent_app_number] => 14/208155
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 30032
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14208155
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/208155 | DIAGNOSIS OF MELANOMA BY NUCLEIC ACID ANALYSIS | Mar 12, 2014 | Abandoned |
Array
(
[id] => 10678437
[patent_doc_number] => 20160024583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'METHODS FOR EVALUATING COPD STATUS'
[patent_app_type] => utility
[patent_app_number] => 14/775379
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12063
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775379
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/775379 | Methods for evaluating COPD status | Mar 12, 2014 | Issued |
Array
(
[id] => 10954550
[patent_doc_number] => 20140357573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'PROGNOSTIC ASSAY FOR SQUAMOUS CELL LUNG CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 14/210124
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13359
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14210124
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/210124 | PROGNOSTIC ASSAY FOR SQUAMOUS CELL LUNG CARCINOMA | Mar 12, 2014 | Abandoned |
Array
(
[id] => 10678441
[patent_doc_number] => 20160024587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'MARKERS ASSOCIATED WITH WNT INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/774212
[patent_app_country] => US
[patent_app_date] => 2014-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18004
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774212
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/774212 | Markers associated with Wnt inhibitors | Mar 9, 2014 | Issued |
Array
(
[id] => 9771104
[patent_doc_number] => 20140294768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'RESPONSIVENESS TO ANGIOGENESIS INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/191040
[patent_app_country] => US
[patent_app_date] => 2014-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19371
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14191040
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/191040 | RESPONSIVENESS TO ANGIOGENESIS INHIBITORS | Feb 25, 2014 | Abandoned |